L. Weaver‐McClure

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

D. Fairclough, T. Delaney, C. Pratt, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.

V. Dilsizian, D. Venzon, F. Balis, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective evaluation of ifosfamide‐related nephrotoxicity in children and young adults

S. Izraeli, F. Balis, L. Wexler, 1995, Cancer.

Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy.

S. Steinberg, P. Pizzo, L. Wexler, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

S. Steinberg, T. Delaney, F. Balis, 1996, Cancer.

Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy.

D. Venzon, T. Kinsella, E. Glatstein, 1991, International journal of radiation oncology, biology, physics.